Independent information. England-wide.Public data. Clear sources.

NCT07517263

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Registered research study with 26 identifiable England locations. See source dates, location-specific recruitment and the original study record.

Study facts

Conditions recorded
Cardiovascular Disease and Lipoprotein(a)
Lead sponsor
Novartis Pharmaceuticals
Study type
Interventional
Overall status
Recruiting · this can differ by location
Age range in the record
18 Years to 100 Years
Sex eligibility field
All
Healthy volunteers accepted
No, according to the record
Phase
Phase3
Study record last updated
4 September 2026
Study team last verified status
2026-09

These fields are a starting point. Eligibility can include diagnosis, treatment history and other criteria shown only in the complete source record. A registry entry does not establish treatment effectiveness.

England study locations

A location is reproduced as named in the study record. A source map point can represent a town; it is not used here as a hospital entrance or to identify a care provider.

Location in the sourceLocal recruitment statusGeographic connection
Novartis Investigative Site

Dorchester · DT1 2JY

RecruitingCare in Dorset

England postcode

Novartis Investigative Site

London · EC1M 6BQ

Active not recruitingCare in Islington

England postcode

Novartis Investigative Site

London · EN3 4GS

RecruitingCare in Enfield

England postcode

Novartis Investigative Site

Preston · PR2 9QB

RecruitingCare in Preston

England postcode

Novartis Investigative Site

Harrow · HA1 3UJ

RecruitingCare in Brent

England postcode

Novartis Investigative Site

Rochdale · OL11 4AU

Active not recruitingCare in Rochdale

England postcode

Novartis Investigative Site

Taunton · TA1 5DA

Active not recruitingCare in Somerset

England postcode

Novartis Investigative Site

Chertsey · KT16 0PZ

Active not recruitingCare in Runnymede

England postcode

Novartis Investigative Site

Newcastle upon Tyne · NE7 7DN

Active not recruitingCare in Newcastle upon Tyne

England postcode

Novartis Investigative Site

Sunderland · SR4 7TP

Active not recruitingCare in Sunderland

England postcode

Novartis Investigative Site

Chichester · PO19 6SE

RecruitingCare in Chichester

England postcode

Novartis Investigative Site

Birmingham · B9 5SS

Active not recruitingCare in Birmingham

England postcode

Novartis Investigative Site

Bristol · BS2 8HW

RecruitingCare in Bristol

England postcode

Novartis Investigative Site

Bromwich · B71 4HJ

RecruitingCare in Sandwell

England postcode

Novartis Investigative Site

Chesterfield · S40 4AA

Active not recruitingCare in Chesterfield

England postcode

Novartis Investigative Site

Leicester · LE3 9QP

RecruitingCare in Leicester

England postcode

Novartis Investigative Site

Liverpool · L7 8XP

RecruitingCare in Liverpool

England postcode

Novartis Investigative Site

London · W12 0HS

RecruitingCare in Hammersmith and Fulham

England postcode

Novartis Investigative Site

Manchester · M13 9WL

Active not recruitingCare in Manchester

England postcode

Novartis Investigative Site

Middlesbrough · TS4 3BW

Active not recruitingCare in Middlesbrough

England postcode

Novartis Investigative Site

Middlesex · UB9 6JH

RecruitingCare in Hillingdon

England postcode

Novartis Investigative Site

Norwich · NR4 7UY

Active not recruitingCare in South Norfolk

England postcode

Novartis Investigative Site

Plymouth · PL6 8DH

RecruitingCare in Plymouth

England postcode

Novartis Investigative Site

Sheffield · S5 7AU

Active not recruitingCare in Sheffield

England postcode

Novartis Investigative Site

Tyne and Wear · NE29 8NH

Active not recruitingCare in North Tyneside

England postcode

Novartis Investigative Site

Wiltshire · SN15 2SB

RecruitingCare in Wiltshire

England postcode

Questions for the research team

  • Is this exact location currently enrolling participants, and do my circumstances meet the full criteria?
  • What visits, tests, possible risks and follow-up would participation involve?
  • Are travel costs or accessibility arrangements available?
  • How would participation affect my usual care, and what happens if I withdraw?

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.